Concepedia

Daniela Bartoletti

DB

Statistics

Publications

18

Citations

560

H-Index

13

Active since

2018

Affiliations

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico(Current)

University of Verona

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

University of Catania

IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola

Daniela Bartoletti is an author at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico specializing in medicine, hematology, and myeloproliferative neoplasms.

ORCID

Publications per year

2018–2023

18

Publications

18

Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis

Francesca Palandri, Massimo Breccia, Massimiliano Bonifacio et al. · Cancer · 2019 · 149 citations · Full text

, , +10

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia

Francesca Palandri, Elena Rossi, Daniela Bartoletti et al. · Blood · 2021 · 55 citations · Full text

, , +10

Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome

Francesca Palandri, Massimo Breccia, Camilla Mazzoni et al. · Cancer · 2023 · 40 citations · Full text

, , +12

Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry

Patrizia Alvisi, Flavio Labriola, Luca Scarallo et al. · Digestive and Liver Disease · 2022 · 37 citations

, , +11

Second primary malignancy in myelofibrosis patients treated with ruxolitinib

Nicola Polverelli, Elena Maria Elli, Elisabetta Abruzzese et al. · British Journal of Haematology · 2020 · 36 citations · Full text

, , +12

1–5 of 18